Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors

ACS Nano

Volumn 7, Issue 9, 2013, Pages 7724-7733

  Mouli, Samdeep K ^a   Tyler, Patrick ^a   McDevitt, Joseph L ^a   Eifler, Aaron C ^a   Guo, Yang ^a   Nicolai, Jodi ^a   Lewandowski, Robert J ^a,c   Li, Weiguo ^a   Procissi, Daniel ^a   Ryu, Robert K ^a,c   Wang, Y Andrew ^d   Salem, Riad ^a,c   Larson, Andrew C ^a,b,c   Omary, Reed A ^e  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b Northwestern University   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d OCEAN NANOTECH LLC   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer therapy; drug delivery; imaging guidance; magnetic nanoparticles; magnetic resonance imaging; tumor targeting

Indexed keywords

CANCER CHEMOTHERAPEUTICS; CANCER THERAPY; IMAGING GUIDANCE; LOCAL DRUG DELIVERY; MAGNETIC NANO-PARTICLES; NANOPARTICLE UPTAKES; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; TUMOR TARGETING;

CELL CULTURE; DRUG DELIVERY; MACHINERY; MAGNETIC RESONANCE IMAGING; NANOPARTICLES;

TUMORS;

ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; DOXORUBICIN; MAGNETITE NANOPARTICLE;

ANIMAL; ARTICLE; ARTIFICIAL EMBOLISM; EXPERIMENTAL NEOPLASM; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; RABBIT; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOXORUBICIN; EMBOLIZATION, THERAPEUTIC; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MAGNETITE NANOPARTICLES; MALE; NEOPLASMS, EXPERIMENTAL; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84884934303     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn4023119     Document Type: Article

References (63)

1. Jain, T. K.; Morales, M. A.; Sahoo, S. K.; Leslie-Pelecky, D. L.; Labhasetwar, V. Iron Oxide Nanoparticles for Sustained Delivery of Anticancer Agents Mol. Pharm. 2005, 2, 194-205
2. Sun, C.; Lee, J. S. H.; Zhang, M. Magnetic Nanoparticles in MR Imaging and Drug Delivery Adv. Drug Delivery Rev. 2008, 60, 1252-1265
3. Kettering, M.; Zorn, H.; Bremer-Streck, S.; Oehring, H.; Zeisberger, M.; Bergemann, C.; Hergt, R.; Halbhuber, K. J.; Kaiser, W. A.; Hilger, I. Characterization of Iron Oxide Nanoparticles Adsorbed with Cisplatin for Biomedical Applications Phys, Med, Biol. 2009, 54, 5109-5121
4. Peng, X-H; Qian, X.; Mao, H.; Wang, A. Y.; Chen, Z. G.; Nie, S.; Shin, D. M. Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy Int. J. Nanomed. 2008, 3, 311-321
5. Yang, L.; Mao, H.; Cao, Z.; Wang, Y. A.; Peng, X.; Wang, X.; Sajja, H. K.; Wang, L.; Duan, H.; Ni, C. et al. Molecular Imaging of Pancreatic Cancer in an Animal Model Using Targeted Multifunctional Nanoparticles Gastroenterology 2009, 136, 1514-1525 e1512
6. Davis, M. E.; Chen, Z. G.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
7. Jain, R. K.; Stylianopoulos, T. Delivering Nanomedicine to Solid Tumors Nat. Rev. Clin. Oncol. 2010, 7, 653-664
8. de la Zerda, A.; Bodapati, S.; Teed, R.; May, S. Y.; Tabakman, S. M.; Liu, Z.; Khuri-Yakub, B. T.; Chen, X.; Dai, H.; Gambhir, S. S. Family of Enhanced Photoacoustic Imaging Agents for High-Sensitivity and Multiplexing Studies in Living Mice ACS Nano 2012, 6, 4694-4701
9. Fang, J.; Nakamura, H.; Maeda, H. The EPR Effect: Unique Features of Tumor Blood Vessels for Drug Delivery, Factors Involved, and Limitations and Augmentation of the Effect Adv. Drug Delivery Rev. 2010, 10.1016/j.addr.2010.04. 009
10. Minchinton, A. I.; Tannock, I. F. Drug Penetration in Solid Tumours Nat. Rev. Cancer 2006, 6, 583-592
11. Dreher, M. R.; Liu, W.; Michelich, C. R.; Dewhirst, M. W.; Yuan, F.; Chilkoti, A. Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers J. Natl. Cancer Inst. 2006, 98, 335-344
12. Danquah, M. K.; Zhang, X. A.; Mahato, R. I. Extravasation of Polymeric Nanomedicines across Tumor Vasculature Adv. Drug Delivery Rev. 2010, 10.1016/j.addr.2010.11.005
13. Huang, X.; Peng, X.; Wang, Y.; Wang, Y.; Shin, D. M.; El-Sayed, M. A.; Nie, S. A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands ACS Nano 2010, 4, 5887-5896
14. Nie, S. Understanding and Overcoming Major Barriers in Cancer Nanomedicine Nanomedicine (London). 2010, 5, 523-528
15. Bartlett, D. W.; Su, H.; Hildebrandt, I. J.; Weber, W. A.; Davis, M. E. Impact of Tumor-Specific Targeting on the Biodistribution and Efficacy of Sirna Nanoparticles Measured by Multimodality in Vivo Imaging Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 15549-15554
16. Kirpotin, D. B.; Drummond, D. C.; Shao, Y.; Shalaby, M. R.; Hong, K.; Nielsen, U. B.; Marks, J. D.; Benz, C. C.; Park, J. W. Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models Cancer Res. 2006, 66, 6732-6740
17. Valastyan, S.; Weinberg, R. A. Tumor Metastasis: Molecular Insights and Evolving Paradigms Cell 2011, 147, 275-292
18. Zhou, B. B.; Zhang, H.; Damelin, M.; Geles, K. G.; Grindley, J. C.; Dirks, P. B. Tumour-Initiating Cells: Challenges and Opportunities for Anticancer Drug Discovery Nat. Rev. Drug Discovery 2009t, 8, 806-823
19. Dreher, M. R.; Liu, W.; Michelich, C. R.; Dewhirst, M. W.; Yuan, F.; Chilkoti, A. Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers J. Natl. Cancer Inst. 2006, 98, 335-344
20. Solomon, S. B.; Silverman, S. G. Imaging in Interventional Oncology Radiology 2010, 257, 624-640
21. Weber, M. A.; Giesel, F. L.; Stieltjes, B. MRI for Identification of Progression in Brain Tumors: From Morphology to Function Expert Rev. Neurother. 2008, 8, 1507-1525
22. Khoo, V. S.; Joon, D. L. New Developments in MRI for Target Volume Delineation in Radiotherapy. Br. J. Radiol. 2006, 79 (Spec No 1), S2-15.
23. Levy, M.; Luciani, N.; Alloyeau, D.; Elgrabli, D.; Deveaux, V.; Pechoux, C.; Chat, S.; Wang, G.; Vats, N.; Gendron, F. Long Term in Vivo Biotransformation of Iron Oxide Nanoparticles Biomaterials 2011, 32, 3988-3999
24. Jain, T. K.; Reddy, M. K.; Morales, M. A.; Leslie-Pelecky, D. L.; Labhasetwar, V. Biodistribution, Clearance, and Biocompatibility of Iron Oxide Magnetic Nanoparticles in Rats Mol. Pharm. 2008, 5, 316-327
25. Winkelmann, S.; Schaeffter, T.; Weiss, S.; Eggers, H.; Doessel, O. Simultaneous Imaging and R 2* Mapping Using a Radial Multi-Gradient-Echo (Rmge) Sequence J. Magn. Reson. Imaging 2006, 24, 939-944
26. Yablonskiy, D. A.; Haacke, E. M. Theory of NMR Signal Behavior in Magnetically Inhomogeneous Tissues: The Static Dephasing Regime Magn. Reson. Med. 1994, 32, 749-763
27. Bremer, C.; Mustafa, M.; Bogdanov, A., Jr.; Ntziachristos, V.; Petrovsky, A.; Weissleder, R. Steady-State Blood Volume Measurements in Experimental Tumors with Different Angiogenic Burdens a Study in Mice Radiology 2003, 226, 214-220
28. Bowen, C. V.; Zhang, X.; Saab, G.; Gareau, P. J.; Rutt, B. K. Application of the Static Dephasing Regime Theory to Superparamagnetic Iron-Oxide Loaded Cells Magn. Reson. Med. 2002, 48, 52-61
29. Yang, L.; Cao, Z.; Sajja, hK; Mao, H.; Wang, L.; Geng, H.; Xu, H.; Jiang, T.; Wood, W. C.; Nie, S. et al. Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging J. Biomed. Nanotechnol. 2008, 4, 439-449
30. Hui, S. W. Overview of Drug Delivery and Alternative Methods to Electroporation Methods Mol. Biol. 2008, 423, 91-107
31. Walczak, P.; Kedziorek, D. A.; Gilad, A. A.; Lin, S.; Bulte, J. W. Instant MR Labeling of Stem Cells Using Magnetoelectroporation Magn. Reson. Med. 2005, 54, 769-774
32. Mir, L. M.; Orlowski, S. The Basis of Electrochemotherapy Methods Mol. Med. 2000, 37, 99-117
33. Tounekti, O.; Pron, G.; Belehradek, J., Jr.; Mir, L. M. Bleomycin, an Apoptosis-Mimetic Drug That Induces Two Types of Cell Death Depending on the Number of Molecules Internalized Cancer Res. 1993, 53, 5462-5469
34. Tounekti, O.; Belehradek, J., Jr.; Mir, L. M. Relationships between DNA Fragmentation, Chromatin Condensation, and Changes in Flow Cytometry Profiles Detected During Apoptosis Exp. Cell Res. 1995, 217, 506-516
35. Mitchell, M. S. Combining Chemotherapy with Biological Response Modifiers in Treatment of Cancer J. Natl. Cancer Inst. 1988, 80, 1445-1450
36. Guo, Y.; Zhang, Y.; Klein, R.; Nijm, G. M.; Sahakian, A. V.; Omary, R. A.; Yang, G-Y; Larson, A. C. Irreversible Electroporation Therapy in the Liver: Longitudinal Efficacy Studies in a Rat Model of Hepatocellular Carcinoma Cancer Res. 2010, 70, 1555-1563
37. Zhang, Y.; Guo, Y.; Ragin, A. B.; Lewandowski, R. J.; Yang, G-Y; Nijm, G. M.; Sahakian, A. V.; Omary, R. A.; Larson, A. C. MR Imaging to Assess Immediate Response to Irreversible Electroporation for Targeted Ablation of Liver Tissues: Preclinical Feasibility Studies in a Rodent Model Radiology 2010, 256, 424-432
38. Coldwell, D.; Sangro, B.; Salem, R.; Wasan, H.; Kennedy, A. Radioembolization in the Treatment of Unresectable Liver Tumors: Experience across a Range of Primary Cancers Am. J. Clin. Oncol. 2012, 35, 167-177
39. Lewandowski, R. J.; Kulik, L. M.; Riaz, A.; Senthilnathan, S.; Mulcahy, M. F.; Ryu, R. K.; Ibrahim, S. M.; Sato, K. T.; Baker, T.; Miller, F. H. et al. A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization versus Radioembolization Am. J. Transplant. 2009, 9, 1920-1928
40. Virmani, S.; Rhee, T. K.; Ryu, R. K.; Sato, K. T.; Lewandowski, R. J.; Mulcahy, M. F.; Kulik, L. M.; Szolc-Kowalska, B.; Woloschak, G. E.; Yang, G. Y. et al. Comparison of Hypoxia-Inducible Factor-1alpha Expression before and after Transcatheter Arterial Embolization in Rabbit Vx2 Liver Tumors J. Vasc. Interventional Radiol. 2008, 19, 1483-1489
41. Gupta, T.; Virmani, S.; Neidt, T. M.; Szolc-Kowalska, B.; Sato, K. T.; Ryu, R. K.; Lewandowski, R. J.; Gates, V. L.; Woloschak, G. E.; Salem, R. MR Tracking of Iron-Labeled Glass Radioembolization Microspheres During Transcatheter Delivery to Rabbit Vx2 Liver Tumors: Feasibility Study Radiology 2008, 249, 845-854
42. Wang, D.; Virmani, S.; Tang, R.; Szolc-Kowalska, B.; Woloschak, G.; Omary, R. A.; Larson, A. C. Four-Dimensional Transcatheter Intraarterial Perfusion (Trip)-MRI for Monitoring Liver Tumor Embolization in Vx2 Rabbits Magn. Reson. Med. 2008, 60, 970-975
43. Virmani, S.; Harris, K. R.; Szolc-Kowalska, B.; Paunesku, T.; Woloschak, G. E.; Lee, F. T.; Lewandowski, R. J.; Sato, K. T.; Ryu, R. K.; Salem, R. et al. Comparison of Two Different Methods for Inoculating Vx2 Tumors in Rabbit Livers and Hind Limbs J. Vasc. Interventional Radiol. 2008, 19, 931-936
44. Deng, J.; Virmani, S.; Young, J.; Harris, K.; Yang, G. Y.; Rademaker, A.; Woloschak, G.; Omary, R. A.; Larson, A. C. Diffusion-Weighted Propeller MRI for Quantitative Assessment of Liver Tumor Necrotic Fraction and Viable Tumor Volume in Vx2 Rabbits J. Magn. Reson. Imaging 2008, 27, 1069-1076
45. Wang, D.; Bangash, A. K.; Rhee, T. K.; Woloschak, G. E.; Paunesku, T.; Salem, R.; Omary, R. A.; Larson, A. C. Liver Tumors: Monitoring Embolization in Rabbits with Vx2 Tumors-Transcatheter Intraarterial First-Pass Perfusion MR Imaging Radiology 2007, 245, 130-139
46. Rhee, T. K.; Young, J. Y.; Larson, A. C.; Haines, G. K., 3rd; Sato, K. T.; Salem, R.; Mulcahy, M. F.; Kulik, L. M.; Paunesku, T.; Woloschak, G. E. et al. Effect of Transcatheter Arterial Embolization on Levels of Hypoxia-Inducible Factor-1alpha in Rabbit Vx2 Liver Tumors J. Vasc. Interventional Radiol. 2007, 18, 639-645
47. Rhee, T. K.; Ryu, R. K.; Bangash, A. K.; Wang, D.; Szolc-Kowalska, B.; Harris, K. R.; Sato, K. T.; Chrisman, H. B.; Vogelzang, R. L.; Paunesku, T. et al. Rabbit Vx2 Tumors as an Animal Model of Uterine Fibroids and for Uterine Artery Embolization J. Vasc. Interventional Radiol. 2007, 18, 411-418
48. Larson, A. C.; Rhee, T. K.; Deng, J.; Wang, D.; Sato, K. T.; Salem, R.; Paunesku, T.; Woloschak, G.; Mulcahy, M. F.; Li, D. et al. Comparison between Intravenous and Intraarterial Contrast Injections for Dynamic 3d MRI of Liver Tumors in the Vx2 Rabbit Model J. Magn. Reson. Imaging 2006, 24, 242-247
49. Deng, J.; Rhee, T. K.; Sato, K. T.; Salem, R.; Haines, K.; Paunesku, T.; Mulcahy, M. F.; Miller, F. H.; Omary, R. A.; Larson, A. C. In Vivo Diffusion-Weighted Imaging of Liver Tumor Necrosis in the Vx2 Rabbit Model at 1.5 T Invest. Radiol. 2006, 41, 410-414
50. Brown, D. B.; Geschwind, J. F.; Soulen, M. C.; Millward, S. F.; Sacks, D. Society of Interventional Radiology Position Statement on Chemoembolization of Hepatic Malignancies J. Vasc. Interventional Radiol. 2009, 20, S317-323
51. Lo, C-M; Ngan, H.; Tso, W-K; Liu, C-L; Lam, C-M; Poon, RT-P; Fan, S-T; Wong, J. Randomized Controlled Trial of Transarterial Lipiodol Chemoembolization for Unresectable Hepatocellular Carcinoma Hepatology 2002 May 1, 35, 1164-1171
52. Llovet, J. M.; Real, M. I.; Montaña, X.; Planas, R.; Coll, S.; Aponte, J.; Ayuso, C.; Sala, M.; Muchart, J.; Solà, R. et al. Arterial Embolisation or Chemoembolisation versus Symptomatic Treatment in Patients with Unresectable Hepatocellular Carcinoma: A Randomised Controlled Trial Lancet 2002, 359, 1734-1739
53. Torchilin, V. Tumor Delivery of Macromolecular Drugs Based on the Epr Effect Adv. Drug Delivery Rev. 2011, 63, 131-135
54. Yu, W. W.; Falkner, J. C.; Yavuz, C. T.; Colvin, V. L. Synthesis of Monodisperse Iron Oxide Nanocrystals by Thermal Decomposition of Iron Carboxylate Salts Chem. Commun. (Cambridge). 2004, 2306-2307
55. Duan, H.; Kuang, M.; Wang, X.; Wang, Y.; Mao, H.; Nie, S. Reexamining the Effects of Particle Size and Surface Chemistry on the Magnetic Properties of Iron Oxide Nanocrystals: New Insights into Spin Disorder and Proton Relaxivity J. Phys. Chem. C 2008, 112, 8127-8131
56. Garin, E.; Denizot, B.; Roux, J.; Noiret, N.; Lepareur, N.; Moreau, M.; Mesba, H.; Laurent, J. F.; Herry, J. Y.; Bourguet, P. et al. Description and Technical Pitfalls of a Hepatoma Model and of Intra-Arterial Injection of Radiolabelled Lipiodol in the Rat Lab. Anim. 2005, 39, 314-320
57. Geschwind, J. F.; Artemov, D.; Abraham, S.; Omdal, D.; Huncharek, M. S.; McGee, C.; Arepally, A.; Lambert, D.; Venbrux, A. C.; Lund, G. B. Chemoembolization of Liver Tumor in a Rabbit Model: Assessment of Tumor Cell Death with Diffusion-Weighted Mr Imaging and Histologic Analysis J. Vasc. Interventional Radiol. 2000, 11, 1245-1255
58. Therasse, P.; Eisenhauer, E. A.; Verweij, J. Recist Revisited: A Review of Validation Studies on Tumour Assessment Eur. J. Cancer 2006, 42, 1031-1039
59. Magill, D.; Mouli, S.; Sandberg, J.; Eifler, A. C.; Belkind, N.; Guo, Y.; Nicolai, J.; Klein, R. A.; Lewandowski, R. J.; Ryu, R. K. et al. Abstract No. 18: The Timing of Electroporation after Delivery of Therapeutic Nanoparticles Affects Drug Uptake in Vx2 Tumors J. Vasc. Interventional Radiol. 2011, 22, S11-S12
60. Gaba, R. C.; Baumgarten, S.; Omene, B. O.; van Breemen, R. B.; Garcia, K. D.; Larson, A. C.; Omary, R. A. Ethiodized Oil Uptake Does Not Predict Doxorubicin Drug Delivery after Chemoembolization in Vx2 Liver Tumors J. Vasc. Interventional Radiol. 2012, 23, 265-273
61. Thompson, S. M.; Callstrom, M. R.; Knudsen, B.; Anderson, J. L.; Carter, R. E.; Grande, J. P.; Roberts, L. R.; Woodrum, D. A. Development and Preliminary Testing of a Translational Model of Hepatocellular Carcinoma for MR Imaging and Interventional Oncologic Investigations J. Vasc. Interventional Radiol. 2012, 23, 385-395
62. Guo, Y.; Klein, R.; Omary, R. A.; Yang, G. Y.; Larson, A. C. Highly Malignant Intra-hepatic Metastatic Hepatocellular Carcinoma in Rats Am. J. Transl. Res. 2010, 3, 114-120
63. Chen, H.; Wang, L.; Yeh, J.; Wu, X.; Cao, Z.; Wang, Y. A.; Zhang, M.; Yang, L.; Mao, H. Reducing Non-specific Binding and Uptake of Nanoparticles and Improving Cell Targeting with an Antifouling Peo-B-Pgammamps Copolymer Coating Biomaterials 2010, 31, 5397-5407